Interleukin-38 ameliorates poly(I:C) induced lung inflammation
By A Mystery Man Writer
Description
Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
Evaluation of interleukin‐38 levels in serum of patients with coronavirus disease 2019 - Al‐bassam - 2022 - Journal of Medical Virology - Wiley Online Library
IJMS, Free Full-Text
Progress of research into the interleukin-1 family in CVD
Frontiers Research progress on the effect of traditional Chinese medicine on the activation of PRRs-mediated NF-κB signaling pathway to inhibit influenza pneumonia
Enhancing autophagy in CD11c+ antigen-presenting cells as a therapeutic strategy for acute respiratory distress syndrome - ScienceDirect
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Inhibition of Polyinosinic-Polycytidylic Acid-Induced Acute Pulmonary Inflammation and NF-κB Activation in Mice by a Banana Plant Extract
Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
Frontiers Circulating interleukin-38 concentrations in healthy adults
Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
Interleukin‐38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2‐p38 pathway‐dependent manner - Kurose - 2023 - Physiological Reports - Wiley Online Library
from
per adult (price varies by group size)